BCTX - Briacell Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

12.72M

Cash

935.7K

Avg Qtr Burn

-7.752M

Short % of Float

4.37%

Insider Ownership

15.56%

Institutional Own.

12.04%

Qtr Updated

04/30/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Bria-IMT™ (SV-BR-1-GM) Details Breast cancer, Cancer	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Bria-OTS™ + tislelizumab Details Breast cancer, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.